Quadrant Capital Group’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.44K | Sell |
133
-42
| -24% | -$798 | ﹤0.01% | 2477 |
|
|
2025
Q4 | $2.76K | Buy |
175
+121
| +224% | +$2.16K | ﹤0.01% | 2466 |
|
|
2025
Q3 | $1.05K | Buy |
+54
| New | +$1.05K | ﹤0.01% | 2553 |
|
|
2025
Q2 | – | Sell |
-8,655
| Closed | -$212K | – | 1386 |
|
|
2025
Q1 | $212K | Buy |
8,655
+8,458
| +4,293% | +$217K | 0.01% | 1274 |
|
|
2024
Q4 | $4.71K | Sell |
197
-638
| -76% | -$20.3K | ﹤0.01% | 2319 |
|
|
2024
Q3 | $35.4K | Sell |
835
-70
| -8% | -$3.67K | ﹤0.01% | 1636 |
|
|
2024
Q2 | $46.4K | Buy |
905
+160
| +21% | +$9.07K | ﹤0.01% | 1448 |
|
|
2024
Q1 | $46.6K | Sell |
745
-666
| -47% | -$45.3K | ﹤0.01% | 1449 |
|
|
2023
Q4 | $106K | Buy |
1,411
+342
| +32% | +$24.5K | 0.01% | 962 |
|
|
2023
Q3 | $91.1K | Sell |
1,069
-275
| -20% | -$26.1K | 0.01% | 926 |
|
|
2023
Q2 | $147K | Buy |
1,344
+284
| +27% | +$26.9K | 0.01% | 662 |
|
|
2023
Q1 | $87.9K | Buy |
1,060
+112
| +12% | +$10.5K | 0.01% | 909 |
|
|
2022
Q4 | $97.5K | Buy |
948
+228
| +32% | +$26.3K | 0.01% | 788 |
|
|
2022
Q3 | $76K | Buy |
720
+442
| +159% | +$48.5K | 0.01% | 826 |
|
|
2022
Q2 | $30K | Sell |
278
-113
| -29% | -$11.2K | ﹤0.01% | 1097 |
|
|
2022
Q1 | $41K | Buy |
391
+136
| +53% | +$14.1K | 0.01% | 1005 |
|
|
2021
Q4 | $31K | Buy |
255
+4
| +2% | +$444 | ﹤0.01% | 1095 |
|
|
2021
Q3 | $29K | Buy |
251
+4
| +2% | +$424 | ﹤0.01% | 1077 |
|
|
2021
Q2 | $24K | Hold |
247
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q1 | $18K | Hold |
247
| – | – | ﹤0.01% | 1220 |
|
|
2020
Q4 | $17K | Buy |
247
+5
| +2% | +$326 | ﹤0.01% | 1156 |
|
|
2020
Q3 | $14K | Sell |
242
-1,152
| -83% | -$60.6K | ﹤0.01% | 1090 |
|
|
2020
Q2 | $63K | Buy |
1,394
+75
| +6% | +$3.59K | 0.01% | 632 |
|
|
2020
Q1 | $77K | Buy |
1,319
+63
| +5% | +$4.31K | 0.01% | 681 |
|
|
2019
Q4 | $76K | Hold |
1,256
| – | – | 0.01% | 1121 |
|
|
2019
Q3 | $70K | Hold |
1,256
| – | – | 0.01% | 1076 |
|
|
2019
Q2 | $66K | Buy |
1,256
+517
| +70% | +$26.2K | 0.01% | 1075 |
|
|
2019
Q1 | $34K | Buy |
739
+497
| +205% | +$27.6K | 0.01% | 1357 |
|
|
2018
Q4 | $13K | Hold |
242
| – | – | ﹤0.01% | 1309 |
|
|
2018
Q3 | $12K | Hold |
242
| – | – | ﹤0.01% | 1195 |
|
|
2018
Q2 | $13K | Hold |
242
| – | – | ﹤0.01% | 1142 |
|
|
2018
Q1 | $13K | Hold |
242
| – | – | ﹤0.01% | 1139 |
|
|
2017
Q4 | $11K | Hold |
242
| – | – | ﹤0.01% | 1124 |
|
|
2017
Q3 | $11K | Hold |
242
| – | – | ﹤0.01% | 1127 |
|
|
2017
Q2 | $8K | Hold |
242
| – | – | ﹤0.01% | 1170 |
|
|
2017
Q1 | $9K | Hold |
242
| – | – | ﹤0.01% | 1100 |
|
|
2016
Q4 | $8K | Hold |
242
| – | – | ﹤0.01% | 1085 |
|
|
2016
Q3 | $7K | Hold |
242
| – | – | ﹤0.01% | 1148 |
|
|
2016
Q2 | $8K | Hold |
242
| – | – | 0.01% | 1077 |
|
|
2016
Q1 | $7K | Buy |
+242
| New | +$6.92K | ﹤0.01% | 1064 |
|
Other funds holding AMN
VCM
VPM
Quadrant Capital Group's AMN Position: Q1 2026 in Review
Quadrant Capital Group reduced its AMN Healthcare (AMN) stake by 24% in Q1 2026, selling an estimated $798 and leaving 133 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.
Quadrant Capital Group first reported a position in AMN in Q1 2016 and has held it in 40 quarters since. The position peaked at $212K in Q1 2025. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Quadrant Capital Group held 133 shares of AMN Healthcare worth $2.44K as of Q1 2026.
- Quadrant Capital Group sold 42 AMN Healthcare shares in Q1 2026, an estimated $798.
- AMN Healthcare made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2477 holding.
- Quadrant Capital Group first reported a position in AMN Healthcare in Q1 2016 and has held it in 40 quarters since.
- Quadrant Capital Group's AMN Healthcare position peaked at $212K in Q1 2025.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.